antibodi
key
molecul
vertebr
immun
system
respons
recognit
bind
target
antigen
high
affin
specif
monoclon
antibodi
mab
use
wide
rang
applic
includ
diagnosi
prevent
treatment
mani
diseas
exampl
success
util
target
vector
direct
drug
radioisotop
therapeut
molecul
target
cell
tissu
immunomodul
function
well
diagnost
tool
identifi
local
molecular
alter
addit
pharmaceut
applic
mab
also
use
modul
plant
trait
gener
diseas
pest
resist
crop
tavladoraki
et
al
nolk
et
al
peschen
et
al
villani
et
al
studi
plant
metabol
pathway
nolk
et
al
antibodi
complex
glycoprotein
consist
four
polypeptid
link
disulfid
bridg
bond
despit
complex
mab
deriv
easili
express
heterolog
system
includ
plant
fischer
et
al
howev
mab
produc
heterolog
system
may
share
precis
structur
function
properti
nativ
molecul
exampl
mab
produc
bacteri
express
system
lack
modif
includ
glycosyl
eukaryot
express
system
could
fail
use
appropri
glycan
group
result
differ
glycosyl
pattern
yeast
exampl
tend
hyperglycosyl
harashima
malissard
et
al
plant
preferenti
introduc
xylos
fucos
residu
fail
use
galactos
syalic
acid
gomord
fay
although
proper
glycosyl
requir
function
mani
mab
note
differ
glycosyl
pattern
alway
lead
loss
function
vitro
vivo
caus
human
chargelegu
et
al
differ
strategi
adopt
circumv
limit
target
mab
endoplasm
reticulum
abolish
glycosyl
site
mutagenesi
avoid
inappropri
glycosyl
product
fact
report
absenc
glycan
case
interfer
correct
assembl
activ
rodriguez
et
al
nuttal
et
al
addit
fascin
approach
requir
sophist
genet
metabol
engin
resid
inactiv
endogen
glycosyltransferas
andor
express
heterolog
mammalian
specif
enzym
host
plant
system
et
al
complet
antibodi
deriv
produc
stabl
plant
transform
technolog
et
al
thank
recent
improv
vector
mab
produc
transient
express
system
quickli
achiev
much
higher
product
level
along
complex
protein
singl
chain
fragment
preserv
element
full
length
immunoglobulin
often
effect
drug
diagnost
tool
mab
due
increas
abil
penetr
target
tissu
reduc
immunogen
rapid
clearanc
chimer
gene
insert
tmv
base
vector
use
express
human
scfv
treatment
lymphoma
nhl
mccormick
et
al
scfv
gener
antibodi
respons
vaccin
anim
effect
vaccin
murin
nhl
tumor
challeng
model
tmv
strategi
provid
speed
versatil
requir
develop
patient
specif
treatment
vaccin
current
undergo
clinic
trial
safeti
immunogen
evalu
human
anoth
exampl
scfv
deriv
small
immun
protein
sip
treat
transmiss
gastroenter
viru
tgev
porcin
coronaviru
sip
express
pvx
gene
insert
vector
cpmv
base
display
vector
use
express
strategi
aim
provid
passiv
protect
enter
infect
upon
oral
deliveri
crude
plant
extract
monger
et
al
sip
fold
correctli
preserv
abil
bind
neutral
tgev
tissu
cultur
moreov
provid
vivo
protect
challeng
tgev
piglet
vaccin
oral
crude
extract
tobacco
plant
research
also
express
full
length
iga
plant
two
separ
pvx
insert
vector
light
chain
lc
heavi
chain
hc
respect
alamillo
et
al
iga
correctli
assembl
plant
tissu
provid
vivo
protect
tgev
piglet
oral
administr
previou
work
verch
et
al
also
indic
possibl
produc
full
size
mab
plant
two
modifi
tmv
base
viral
vector
result
clearli
indic
possibl
obtain
function
mab
plant
express
system
nonetheless
express
heterooligomer
protein
mab
might
ineffici
due
viral
vector
built
viru
backbon
fact
featur
may
result
earli
segreg
subsequ
preferenti
amplif
one
vector
one
cell
problem
recent
overcom
util
two
set
vector
deriv
tmv
pvx
express
two
differ
mab
chain
giritch
et
al
tmv
pvx
may
interact
differ
host
protein
sustain
replic
movement
without
interf
result
neither
two
vector
gain
replic
advantag
allow
effici
hc
lc
cell
level
express
vector
independ
within
cell
reach
mgg
fw
full
assembl
mab
week
strategi
repres
use
platform
rapid
manufactur
mab
protein
especi
situat
requir
rapid
respons
pandem
threat
bioterror
event
vaccin
antigen
prepar
use
establish
immun
diseas
vaccin
one
greatest
revolut
medic
scienc
dramat
improv
qualiti
length
life
expect
although
vaccin
cost
effect
form
diseas
protect
healthcar
cost
still
excess
mani
peopl
world
especi
develop
countri
vaccin
therapeut
overcom
infect
alreadi
establish
prophylact
prevent
futur
infect
aim
vaccin
strategi
obtain
effici
safe
vaccin
formul
induc
long
last
immun
variou
pathogen
achiev
goal
vaccin
compon
gener
neutral
antibodi
respons
memori
b
cell
stimul
also
cell
mediat
immun
elimin
infect
cell
repres
pathogen
reservoir
recombin
subunit
vaccin
base
singl
protein
antigen
singl
peptid
epitop
deriv
pathogen
particularli
attract
strategi
compar
classic
inactiv
attenu
live
recombin
vaccin
recombin
subunit
vaccin
offer
potenti
equival
efficaci
much
safer
case
easier
produc
plant
offer
uniqu
advantag
product
subunit
vaccin
term
scale
speed
cost
yield
safeti
first
work
describ
express
hepat
b
surfac
antigen
stabl
transgen
tobacco
mark
begin
develop
low
cost
vaccin
formul
plant
mason
et
al
research
focus
express
antigen
edibl
plant
tissu
oral
vaccin
open
new
prospect
vaccin
deliveri
mor
et
al
sinc
mani
research
group
adopt
system
carri
studi
area
improv
target
protein
express
level
analyz
administr
rout
schedul
choos
appropri
anim
model
explor
use
possibl
adjuv
first
report
area
describ
express
fmdv
structur
protein
gene
insert
vector
wigdorovitz
et
al
yield
approxim
mgg
fw
achiev
subsequ
antigen
administ
mice
without
purif
mice
immun
intraperiton
develop
protect
immun
respons
experiment
challeng
virul
fmdv
great
number
antigen
produc
plant
differ
immunolog
result
streatfield
howard
altogeth
work
demonstr
antigen
retain
antigen
abl
induc
activ
protect
humor
immun
respons
develop
plant
deriv
vaccin
human
veterinari
use
viral
patholog
tumor
allergi
bacteri
infect
autoantigen
extens
investig
tabl
yusibov
et
al
express
oncoprotein
human
papilloma
viru
hpv
n
benthamiana
plant
gene
replac
vector
antigen
subsequ
purifi
infect
leav
use
thermotoler
properti
lichenas
massa
et
al
mice
immun
subcutan
show
specif
antibodi
cytotox
respons
dose
also
protect
anim
challeng
tumor
cell
moreov
recombin
antigen
abl
prevent
tumor
develop
administ
viru
challeng
support
ultim
goal
produc
vaccin
therapeut
prophylact
use
fundament
revolut
within
last
year
came
use
modular
deconstruct
system
recent
work
use
magnicon
tmv
base
system
worth
note
santi
et
al
focus
product
antigen
agent
biolog
warfar
exampl
yersinia
pesti
bacterium
caus
agent
plagu
work
protect
efficaci
fraction
capsular
antigen
low
calcium
respons
virul
antigen
v
express
level
mgg
fw
n
benthamiana
leav
evalu
guinea
pig
immun
purifi
antigen
show
serum
igg
titer
importantli
anim
protect
aerosol
challeng
virul
pesti
subsequ
work
mett
et
al
express
pesti
v
antigen
n
benthamiana
plant
averag
yield
mgg
fw
lichenas
optim
vector
purifi
protein
administ
subcutan
primat
cynomolgu
macaqu
produc
antigen
specif
igg
iga
respons
result
complet
protect
lethal
challeng
pesti
recent
work
show
particular
interest
emerg
diseas
well
agent
biolog
warfar
extend
vaccin
develop
smallpox
golovkin
et
al
anthrax
chichest
et
al
dengu
viru
saejung
et
al
avian
influenza
viru
nemchinov
natilla
altogeth
data
collect
show
establish
portfolio
well
character
novel
improv
strategi
express
effect
vaccin
plant
peptid
vaccin
particular
subclass
subunit
vaccin
base
abil
immunodomin
epitop
induc
specif
immun
respons
epitop
import
region
antigen
interact
directli
surfac
receptor
b
cell
induc
immun
respons
singl
protein
sever
epitop
differ
immunolog
featur
structur
epitop
linear
determin
amino
acid
sequenc
conform
determin
neighbor
amino
acid
tridimension
tertiari
structur
epitop
alon
could
poorli
immunogen
often
possess
short
serum
lien
lowman
result
extens
effort
direct
develop
new
deliveri
strategi
increas
immunogen
epitop
vaccin
purcel
et
al
plant
viral
display
vector
potenti
play
import
role
strateg
develop
plant
viru
particl
structur
function
scaffold
support
stabil
display
epitop
peptid
exampl
target
epitop
genet
fuse
cp
protein
chimer
virion
form
fusion
repres
vaccin
result
plant
virus
use
carrier
stabil
epitop
present
correctli
immun
system
strategi
use
amber
leaki
stop
codon
peptid
describ
earlier
adopt
success
display
peptid
turpen
et
al
marconi
et
al
well
protein
fusion
obrien
et
al
addit
new
strategi
involv
biotinyl
capsid
subsequ
bind
target
protein
develop
display
long
sequenc
canin
oral
papillomaviru
protein
display
tmv
surfac
strategi
significantli
immunogen
anim
model
compar
uncoupl
antigen
smith
et
al
strategi
also
possibl
combin
helper
epitop
peptid
known
facilit
cellular
uptak
addit
target
avoid
use
adjuv
coexpress
cytotox
lymphocyt
ctl
epitop
tmv
scaffold
stimul
effect
tumor
protect
challeng
show
signific
surviv
improv
singl
peptid
alon
mccormick
et
al
capabl
cvp
induc
antibodi
respons
specif
display
epitop
upon
intranas
intraperiton
oral
administr
extens
demonstr
differ
anim
model
tabl
data
show
cvp
abil
elicit
strong
specif
neutral
immun
respons
absenc
adjuv
yusibov
et
al
brennan
et
al
marus
et
al
oral
deliveri
spinach
leav
infect
cvp
elicit
strong
antibodi
respons
display
rabi
viru
peptid
mice
human
volunt
yusibov
et
al
indic
potenti
use
system
supplementari
oral
booster
rabi
vaccin
alfalfa
mosaic
viru
amv
cvp
abl
elicit
respons
primat
yusibov
et
al
chimer
tmv
particl
shown
abl
directli
interact
stimul
mammalian
antigen
present
cell
induc
strong
cellular
immun
respons
mccormick
et
al
studi
bodi
distribut
oral
administ
cvp
also
suggest
applic
nanocapsul
novel
drug
deliveri
system
rae
et
al
smith
et
al
applic
cvp
extend
far
beyond
area
vaccin
develop
particular
interest
killer
peptid
confer
resist
phytopathogen
donini
et
al
peptid
convert
cvp
artifici
sink
metal
toler
phytoremedi
shingu
et
al
mosquito
decapeptid
larvicid
protect
plant
agricultur
insect
pest
control
vector
mosquito
borovski
et
al
final
werner
et
al
fuse
fragment
protein
tmv
cp
via
linker
chimer
nanoparticl
allow
simpl
purif
mab
recoveri
yield
product
puriti
greater
technolog
provid
inexpens
matrix
could
use
industri
antibodi
purif
due
simpl
macromolecular
organ
assembl
capabl
structur
stabil
easi
scalabl
facil
purif
plant
virus
offer
cheap
sourc
biopolym
nanoparticl
well
character
virus
stabl
highli
order
repetit
structur
tmv
cpmv
particular
interest
exampl
cpmv
cowpea
chlorot
mottl
viru
ccmv
icosahedr
virus
use
nucleat
cage
miner
materi
dougla
young
anoth
promis
applic
noninvas
vivo
vascular
imag
techniqu
manchest
singh
cpmv
exampl
fluoresc
label
visual
blood
flow
period
least
h
identifi
vessel
monitor
tumor
neovascular
lewi
et
al
moreov
cpmv
modifi
gener
new
surfac
properti
develop
novel
biomateri
electrochem
biosensor
nanoelectron
devic
wang
et
al
chatterji
et
al
steinmetz
et
al
virus
like
tmv
extens
use
synthesi
varieti
metal
nanowir
magnet
materi
semiconductor
tmv
use
organ
templat
control
deposit
gold
silver
platinum
prepar
array
dujardin
et
al
modifi
cp
monom
tmv
also
employ
construct
photovolta
compon
novel
system
miller
et
al
cvp
also
incorpor
liquid
crystal
system
use
gener
thin
film
fiber
flynn
et
al
exampl
clearli
demonstr
broad
applic
emerg
potenti
plant
virus
nanotechnolog
field
first
step
biomateri
process
extract
purif
tissu
high
concentr
target
recombin
protein
select
harvest
target
tissu
reduc
volum
initi
biomateri
turn
reduc
unnecessari
need
elimin
extra
host
protein
introduc
inclus
tissu
total
oper
cost
select
also
allow
avoid
tissu
hard
process
prime
introduc
environment
contamin
eg
root
rich
undesir
molecul
proteas
alkaloid
phenol
transient
express
viral
vector
leav
primarili
target
tissu
protein
accumul
current
biomateri
product
vector
accomplish
green
hous
control
environ
exampl
day
inocul
n
benthamiana
leav
select
harvest
away
root
stem
werner
et
al
small
scale
prepar
research
perform
fraction
leav
manual
separ
central
vein
rest
leav
product
kind
oper
becom
impract
whole
leav
process
thoroughli
next
step
biomateri
produc
open
field
extra
step
perform
remov
divers
array
environment
contamin
rins
light
wash
plant
harvest
target
tissu
common
practic
purpos
regardless
biomateri
gener
import
lower
bioburden
contamin
much
possibl
step
measur
prevent
microorgan
contamin
enter
purif
feed
stream
thu
greatli
simplifi
subsequ
purif
process
ensur
regulatori
complianc
final
product
one
critic
factor
choos
plant
express
platform
protein
stabil
target
tissu
advantag
viral
base
transient
express
system
recombin
protein
gener
less
stabil
leav
due
higher
water
content
contrast
stabl
transform
express
system
doran
howev
protein
show
rel
stabil
leav
day
room
temperatur
fiedler
et
al
even
longer
week
dri
alfalfa
tissu
khoudi
et
al
depend
natur
target
protein
need
process
fresh
leaf
tissu
other
store
month
frozen
tissu
without
lose
recoveri
andor
biolog
activ
chen
unpublish
work
possibl
store
tissu
cold
temperatur
certain
protein
offer
expand
flexibl
product
platform
major
goal
process
step
releas
target
protein
liquid
buffer
solut
plant
tissu
achiev
goal
transient
express
system
leaf
tissu
first
ground
presenc
desir
extract
buffer
break
tissu
cell
tissu
homogen
press
releas
protein
aqueou
buffer
crude
extract
clarifi
separ
buffer
plant
debri
insolubl
protein
see
particul
matter
comparison
product
host
plant
produc
solid
debri
total
weight
biomateri
menkhau
et
al
larger
denser
solid
make
imposs
achiev
effect
clarif
filtrat
method
result
continu
centrifug
remain
effect
scalabl
techniqu
plant
extract
clarif
note
possibl
extract
small
recombin
protein
kda
target
endomembran
system
apoplast
without
break
plant
cell
exampl
smaller
protein
releas
directli
extract
buffer
simpli
rins
tissu
special
centrifug
techniqu
lohau
et
al
purif
process
class
protein
greatli
simplifi
result
reduct
host
protein
contamin
choic
extract
buffer
care
determin
base
properti
eg
pi
size
hydrophob
stabil
target
protein
major
contamin
host
molecul
exampl
major
contamin
protein
plant
leav
ribulos
rubisco
correspondingli
choic
low
ph
buffer
encourag
keep
rubisco
insolubl
prevent
extract
aqueou
phase
laboratori
bench
scale
proteas
inhibitor
antioxid
routin
ad
extract
buffer
counter
denatur
degrad
structur
modif
proteas
phenol
compound
due
regulatori
restraint
requir
molecul
includ
deem
absolut
necessari
product
chromatograph
method
employ
purifi
pharmaceut
protein
like
protein
product
host
purif
strategi
formul
individu
protein
base
solubl
size
pi
charg
hydrophob
affin
specif
ligand
parallel
characterist
host
protein
pmp
protein
chromatographi
provid
superb
conveni
step
langon
much
effort
need
elimin
plant
host
molecul
caus
resin
foul
orand
interfer
bind
target
protein
protein
resin
thu
reduc
capac
scalabl
process
aqueou
partit
system
atp
develop
address
key
issu
plati
labrou
vaccin
therapeut
purif
scheme
develop
individu
base
multipl
step
convent
chromatograph
method
menkhau
et
al
challeng
process
call
need
develop
univers
versatil
purif
method
employ
affin
tag
particularli
tandem
affin
tag
purif
tap
strategi
provid
possibl
versatil
solut
lichti
et
al
arnau
et
al
tagwerk
et
al
howev
search
effici
precis
proteas
tag
remov
still
present
seriou
challeng
addit
inclus
proteas
manufactur
process
complic
product
purif
well
rais
cost
regulatori
concern
feeney
et
al
kenig
et
al
sever
affin
tag
remov
techniqu
explor
et
al
wood
et
al
still
requir
optim
becom
practic
product
manufactur
addit
nativ
protein
carbohydr
host
molecul
uniqu
plant
endogen
molecul
phenol
need
remov
purif
phenol
tend
modifi
protein
form
complex
thu
imped
purif
remov
earlier
purif
kusnadi
et
al
menkhau
et
al
plant
tobacco
also
produc
toxic
alkaloid
elimin
final
product
twyman
et
al
regard
agroinfect
potenti
endotoxin
lipopolysaccharid
lp
bacterium
anoth
concern
specif
purif
strategi
lower
lp
accept
level
must
incorpor
overal
scheme
ensur
safeti
pmp
produc
use
platform
magalha
et
al
overal
purif
design
robust
scalabl
compliant
cgmp
regul
ideal
three
chromatograph
step
includ
obtain
highli
purifi
product
otherwis
recoveri
drop
impract
level
whenev
possibl
resin
wide
accept
standard
pharmaceut
industri
consid
first
minim
futur
regulatori
expenditur
requir
independ
qualiti
manag
system
qm
govern
manufactur
pharmaceut
also
appli
pmp
addit
cgmp
complianc
downstream
process
analyt
test
releas
final
purifi
product
address
plant
specif
contamin
addit
standard
requir
assay
even
though
plant
contain
anim
virus
infecti
agent
must
valid
lp
phenol
alkaloid
well
herbicid
insecticid
adequ
remov
final
product
signific
increas
demand
high
qualiti
recombin
protein
alreadi
horizon
new
biolog
system
product
protein
must
develop
meet
market
demand
plant
express
system
base
viral
vector
greatest
potenti
provid
technolog
optim
implement
commerci
scale
express
system
creat
technolog
platform
produc
recombin
protein
scalabl
speed
effici
safeti
